| Literature DB >> 33253559 |
Giuseppe Sciortino1,2, Manuel Aureliano3, Eugenio Garribba1.
Abstract
The experimental data collected over the past 15 years on the interaction of decavanadate(V) (V10O286-; V10), a polyoxometalate (POM) with promising anticancer and antibacterial action, with G-actin, were rationalized by using several computational approaches (docking, density functional theory (DFT), and molecular dynamics (MD)). Moreover, a comparison with the isostructural and more stable decaniobate(V) (Nb10O286-; Nb10) was carried out. Four binding sites were identified, named α, β, γ, and δ, the site α being the catalytic nucleotide site located in the cleft of the enzyme at the interface of the subdomains II and IV. It was observed that the site α is preferred by V10, whereas Nb10 is more stable at the site β; this indicates that, differently from other proteins, G-actin could contemporaneously bind the two POMs, whose action would be synergistic. Both decavanadate and decaniobate induce conformational rearrangements in G-actin, larger for V10 than Nb10. Moreover, the binding mode of oxidovanadium(IV) ion, VIVO2+, formed upon the reduction of decavanadate(V) by the -SH groups of accessible cysteine residues, is also found in the catalytic site α with (His161, Asp154) coordination; this adduct overlaps significantly with the region where ATP is bound, accounting for the competition between V10 and its reduction product VIVO2+ with ATP, as previously observed by EPR spectroscopy. Finally, the competition with ATP was rationalized: since decavanadate prefers the nucleotide site α, Ca2+-ATP displaces V10 from this site, while the competition is less important for Nb10 because this POM shows a higher affinity for β than for site α. A relevant consequence of this paper is that other metallodrug-protein systems, in the absence or presence of eventual inhibitors and/or competition with molecules of the organism, could be studied with the same approach, suggesting important elements for an explanation of the biological data and a rational drug design.Entities:
Year: 2020 PMID: 33253559 PMCID: PMC8016201 DOI: 10.1021/acs.inorgchem.0c02971
Source DB: PubMed Journal: Inorg Chem ISSN: 0020-1669 Impact factor: 5.165
Figure 1(a) The four binding sites found by docking for V10 and Nb10 in the structure of G-actin. The positively charged side chains of Arg and Lys, which interact with POMs in each site, are depicted as blue balls. Subdomains (I to IV) of G-actin are shown with different colors (orange, blue, purple, and green). (b) Comparison of the DFT optimized structure of V10 and Nb10. Volume (V in Å3) and surface area (A in Å2) were computed by considering van der Waals (vdW) radii. V is shown in gray, Nb in mint, and O in red.
Figure 2EXAFS profile of the systems containing V10 (in black), V10–G-actine (in brown), and V10–G-actin–ATP (in purple). Adapted from ref (15).
Figure 3Molecular dynamics (MD) most sampled structures showing (a) the cleft opening upon the POMs binding (apo G-actin, V10–G-actin, and Nb10–G-actin are shown in green, orange, and blue, respectively), (b) binding mode of V10 at the site α, and (c) binding mode of Nb10 at the site α. The interacting side chains are explicitly depicted.
Figure 4Molecular dynamics (MD) most sampled structures showing (a) the binding mode of V10 at the site β, (b) the binding mode of Nb10 at the site β, and (c) the binding mode of Nb10 at the site γ. The interacting side chains are explicitly depicted.
MD Residence Time of V10 and Nb10 at the Identified Sites (α, β, γ, and δ) and Binding Effects on the G-Actin Folding
| site | subdomain(s) | V10 ( | Δ(Δ | Nb10 ( | Δ(Δ | fold |
|---|---|---|---|---|---|---|
| α | I/IV | stable, 200 | 0.0 | stable, 200 | 2.0 | φ variation |
| β | II | stable, 200 | 22.9 | stable, 200 | 0.0 | retained |
| γ | III | unstable, <75 | stable, 200 | 17.2 | retained | |
| δ | I/III | unstable, <40 | unstable, <5 |
MM-GBSA relative values including quasi-harmonic entropic correction computed on 100 homogeneously distributed frames of the whole MD trajectories (values in kcal mol–1).
φ = 28.6° (apo form), φ = 30.5° (adduct with Nb10), and φ = 35.6° (adduct with V10). The angle φ is defined in the text.
Figure 5X-band EPR spectra recorded on frozen aqueous solution containing (a) 2.5 mM V10 in 2 mM Tris, 0.2 mM CaCl2, 0.2 mM ATP (pH 7.5); (b) 2.5 mM V10 in 2 mM Tris, 0.2 mM CaCl2, plus 100 μM G-actin (pH 7.5); and (c) 2.5 mM V10 in 2 mM Tris, 0.2 mM CaCl2, plus 50 μM G-actin and 0.2 mM of ATP to prevent oxidovanadium(IV) formation (pH 7.5). Adapted from refs (13 and 14).
Full DFT Refined Structures (from the Docking Proposals), Estimated (estmtd) and DFT Calculated (calcd) |A| Values, and Electronic Binding Energies for the Binding of VIVO2+ Ion to the Nucleotide Site α of G-Actin
| donors | distances | pop. (%) | Δ | | | | | ||
|---|---|---|---|---|---|---|---|
| (NH161, COO–D154);
OW; OW | 2.100, 1.964 | 34.1 | 31.8 | 60 | –28.4 | 178.4 | 178.6 |
| (NH73, NH161); OW; OW | 2.128,
2.101 | 45.4 | 39.5 | 64 | –13.2 | 173.4 | 169.4 |
Distance in Å.
GoldScore Fitness value obtained for the more stable pose of each cluster.
Average value of GoldScore Fitness for each cluster.
Percentage computed considering the total solutions reported (numbers of solutions per cluster).
ΔEbind in kcal mol–1.
|A| estimated (estmtd) with the “additivity relationship” in 10–4 cm–1 units.
|A| calculated (calcd) with DFT methods in 10–4 cm–1 units.
H2O molecules cis to each other.
V–NH161 and V–OD154 distances, respectively.
The experimental value of |A| is 177.1 × 10–4 cm–1.
H2O molecules trans to each other.
V–NH73 and V–NH161 distances, respectively.
Figure 6Full DFT optimized structures of the two docking proposals for the binding of VIVO2+ moiety to the nucleotide binding site α of G-actin: (a) the binding mode with (His73, His161), (b) the binding mode with (His161, Asp154), and (c) surface volume of ATP in its native site superimposed with the favored VIVO2+ binding. H-bonds are explicitly indicated with the blue lines.
Figure 7Molecular representation of (a) the contemporaneous binding of V10 at the site α and Nb10 at site β and (b) the binding mode of V10 and Nb10 at the site β in the presence of Ca2+-ATP.